Abstract
Aims: Human leukocyte antigen (HLA) polymorphism influences immunity by balancing protection against pathogens with the preservation of self-tolerance. This balance has been proposed to affect longevity, as associations with HLA variants have been identified. However, studies in this field have reported inconsistent findings due to small sample sizes and low-resolution genotyping methods. We aimed to identify HLA alleles linked with longevity by overcoming these previous limitations.
Methods: We performed high-resolution HLA genotyping using targeted sequencing (HLA-seq) in 1,265 long-lived individuals (LLI; ≥94 years) from Germany and compared their HLA allele frequencies to a large control population of 3.4 million individuals from the German Bone Marrow Donor Registry (DKMS) using χ2 (chi-square) tests.
Results: Six HLA alleles were significantly associated with longevity. Of those, two exhibited the most robust associations: A*01:01g (OR=0.87; 95% CI: 0.80-0.95; adj. P=0.02) and DRB1*13:02g (OR=1.24; 95% CI: 1.10-1.41; P=0.01). DRB1*13:02g was replicated in the UK Biobank after Bonferroni correction, whereas A*01:01g showed directionally concordant nominal support but did not remain significant after multiple-testing correction.
Conclusions: Both DRB1*13:02g and A*01:01g have previously been implicated in dementia-related phenotypes. These observations support the hypothesis that HLA variation may influence longevity partly through pathways linked to neurodegeneration. This study provides a high-resolution (2-field) HLA data of a longevity cohort, which would be valuable for future investigations.
Keywords
References
-
3. Caruso C, Candore G, Colonna Romano G, Lio D, Bonafè M, Valensin S, et al. HLA, aging, and longevity: A critical reappraisal. Hum Immunol. 2000;61(9):942-949.[DOI]
-
8. Mendoza-Mejía N, Kolbe D, Özer O, Dose J, Torres GG, Franke A, et al. HLA-DRB1*15: 01 is associated with a reduced likelihood of longevity in northern European men. Genome Med. 2025;17(1):125.[DOI]
-
11. Nebel A, Croucher PJP, Stiegeler R, Nikolaus S, Krawczak M, Schreiber S. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc Natl Acad Sci U S A. 2005;102(22):7906-7909.[DOI]
-
13. Schetelig J, Baldauf H, Rave C, Bug G, Mueller LPH, Wagner Drouet E, et al. Unrelated donors below 35 years of age should be preferred over HLA-matched sibling donors older than 50 years for patients with myeloid malignancies. Blood. 2023;142(Suppl 1):1046.[DOI]
-
14. Wittig M, Juzenas S, Vollstedt M, Franke A. High-resolution HLA-typing by next-generation sequencing of randomly fragmented target DNA. In: Boegel S, editor. HLA typing: Methods and protocols. New York: Humana Press; 2018. p. 63-88.[DOI]
-
15. Claeys A, Merseburger P, Staut J, Marchal K, Van den Eynden J. Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data. BMC Genomics. 2023;24(1):247.[DOI]
-
19. Meyer HV. meyer-lab-cshl/plinkQC: plinkQC 0.3.2. Version v0.3.2 [software]. Zenodo. 2020.[DOI]
-
22. Dutta A, Henley W, Robine JM, Llewellyn D, Langa KM, Wallace RB, et al. Aging children of long-lived parents experience slower cognitive decline. Alzheimers Dement. 2014;10(5S):S315-S322.[DOI]
-
23. Robinson J, Barker DJ, Marsh SGE. 25 years of the IPD-IMGT/HLA D atabase. HLA. 2024;103(6):e15549.[DOI]
-
28. James LM, Charonis SA, Georgopoulos AP. Association of dementia human leukocyte antigen (HLA) profile with human herpes viruses 3 and 7: An in silico investigation. J Immunol Sci. 2021;5(3):7-14.[DOI]
-
29. Collaborators GBD 2019. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019. Alzheimers Dement (N Y). 2021;7(1):e12200.[DOI]
-
31. Monteiro SP, do Brasil PEAA, Cabello GMK, De Souza RV, Brasil P, Georg I, et al. HLA-A*01 allele: A risk factor for dengue haemorrhagic fever in Brazil’s population. Mem Inst Oswaldo Cruz. 2012;107(2):224-230.[DOI]
-
32. Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood. 2007;110(9):3310-3315.[DOI]
-
37. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.[DOI]
Copyright
© The Author(s) 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Publisher’s Note
Share And Cite


